chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient started having seizure like activity and weakness in her arms and legs; the patient was brought by EMS to the ER and admitted for testing.  She had tics that were occurring of her head and neck area.  After she was released with no abnormalities noted to be causing her symptoms, she was referred to a Functional Movement Disorder specialist at a clinic, who diagnosed her with Functional Movement Disorder.  Her symptoms resolved completely about a week after her hospitalization.
DIZZINESS; CHILLS; FEVER; NAUSEA; MUSCLE SPASMS; GAS PAIN; This spontaneous report received from a patient concerned a 67 year old female. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808978, and batch number: 1808978 expiry: UNKNOWN) dose was not reported, administered on 24-MAR-2021 13:00, in the left arm, for prophylactic vaccination. No concomitant medications were reported. On 24-MAR-2021, the subject experienced muscle spasms. On 24-MAR-2021, the subject experienced gas pain. On 24-MAR-2021 18:00, the subject experienced dizziness. On 24-MAR-2021 18:00, the subject experienced chills. On 24-MAR-2021 18:00, the subject experienced fever. On 24-MAR-2021 18:00, the subject experienced nausea. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from chills on 24-MAR-2021, and had not recovered from fever, nausea, dizziness, muscle spasms, and gas pain. This report was non-serious.
Symptoms of dermatographia (Raised red lines, Swelling, Inflammation, Hive-like welts, Itching) and tinnitus. Tinnitus has resolved, but itching and welts continue. Treated at home with anti-histamines. Has not visited a physician to date
kidney stones; severe left flank pain; extreme thirst; This is a spontaneous report from contactable consumer (patient). A 19-year-old female patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in Arm Left on 10May2021 14:00 (Lot Number: EW0168) as single dose (at the age of 19-years-old) for COVID-19 immunization. The patient was not pregnant at the time of vaccination. There was no medical history. Concomitant medications included lisdexamfetamine mesilate (VYVANSE), cefalexin monohydrate (LEXIPRON), ethinylestradiol, levonorgestrel (VIENVA), all taken for unspecified indications, start and stop dates were not reported. The patient previously received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in Arm Left on 19Apr2021 02:00 PM  (Lot Number: EW0162) as single dose (at the age of 19-years-old) for COVID-19 immunization and experienced Heavy period off schedule from pill pack. The patient experienced extreme thirst since second dose (10May2021). Then, on 27May2021, had severe left flank pain causing an emergency room visit. Preliminary diagnosis is kidney stones. At ER, patient received pain medication, saline hydration drip. The outcome of the events was recovering. The event kidney stones was considered as serious (medically significant).  Facility where the most recent COVID-19 vaccine was administered was the Hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the was not patient diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19.  Follow-up attempts are possible; further information has been requested.
HPI: Patient presents for a near syncopal episode when getting covid  vaccine today. Mother states he was feeling nervous before the shot  and during the incident he felt faint but did not pass out. No LOC  or head injury. He denies any CP, heart palpitations, SOB or  difficulty breathing currently. BS 109.
Information has been received from a registered nurse concerning a 34 year old female with no allergies who was vaccinated with a dose of varicella virus vaccine live on an unspecified date. There was no concomitant medication. In May 2005 a varicella titer was performed and it was reported that the recent titer is equivocal. The RN reported that the patient had not recovered. No product quality complaint was involved. Additional information has been requested.
Bell?s palsy on Oct 4, 2022.  Nerves on right side of face affected. Vocal cords, right ear numb and can?t hear, right eye lid won?t close, right side of face droopy.  Today all symptoms still effected except face nerves not droopy, smile almost 90% back. Throat nerves affected makes it hard to swallow food or drink (lost 20lbs).
Headache; Chills; Fatigue; This is a spontaneous report received from a non-contactable consumer, the patient. A 39-year-old non-pregnant female patient received her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration in the right arm on 16Mar2021 at 10:30 (at the age of 39-years-old), as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications included vitamin D3 (MANUFACTURER UNKNOWN), multivitamin (MANUFACTURER UNKNOWN) and probiotic (MANUFACTURER UNKNOWN), all for unknown indications from unknown dates and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 17Mar2021 at 11:00, the patient experienced headache, chills and fatigue. The patient did not receive any treatment for the adverse events. The clinical outcome of the events headache, chills and fatigue was recovering.   Information about lot/batch number cannot be obtained. No further information is expected.
Arrived to ED on 8/17/22 with 3-4 days of SOB, cough, and wheezing. Tested positive for COVID on 8/17/22.
LOSS OF TASTE; LOSS OF SMELL; CHILLS; RAPID HEART BEAT; HEADACHE; MUSCLE ACHES; FATIGUE; This spontaneous report received from a parent concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown, expiry: UNKNOWN) dose was not reported, administered on 10-MAR-2021 13:00 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On 10-MAR-2021, the subject experienced loss of taste. On 10-MAR-2021, the subject experienced loss of smell. On 10-MAR-2021, the subject experienced chills. On 10-MAR-2021, the subject experienced rapid heart beat. On 10-MAR-2021, the subject experienced headache. On 10-MAR-2021, the subject experienced muscle aches. On 10-MAR-2021, the subject experienced fatigue. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from rapid heart beat on 10-MAR-2021, had not recovered from headache, loss of taste, loss of smell, muscle aches, and chills, and the outcome of fatigue was not reported. This report was non-serious.; Sender's Comments: V0. medical assessment comment not required as per standard procedure as the case was assessed as non-serious.
Sudden sweatiness, nausea and tunnel vision.   Very brief LOC. Immediately better when placed supine.   More scarred than anything else. No fall or injury. BP/pulse/O2 saturation all Normal    Initial 126/89, 69, 100%.    No orthostasis. Classic vasovagal reaction.    Resolved.
METALLIC TASTE IN MOUTH,  RASH ON LATERAL  ASPECTS OF BOTH SIDES OF TONGUE TOWARD  APEX AND ITCHY TONGUE.   GENERAL MALAIASE 2/2/2021 AND 2/3/21.  TEMP TAKEN ON BOTH DAYS WITH READINGS  BETWEEN 99.4-99.7 DEGREES.  TOOK ACETAMINOPHEN 2/2/21 AND BENADRYL ON 2/4/21.  TONGUE ITCH SUBSIDED POST 1 DOSE (2 CAPS) OF BENADRYL.  RASH PERSISTS AT THE TIME OF THIS WRITING.
Mother called stating school nurse had reported a swelling at injection site on left arm. School nurse advised taking child to PCP for assessment. Mother had not seen child yet, unaware of any other S/Sx.
Wife stated that one month after receiving his 2nd dose of moderna vaccine, patient started to develop a bruise that's red and the size of a dime on right arm. The same bruise travels from right arm to left arm
Ringing in ears, extreme pain in injection site, migraine, chest pain, joint pain , fever, neck pain, metallic taste in mouth, itching, and body aches
About 1/2 hour after vaccination face and neck got very hot and red. It lasted about two hours, gradually cooling off.
Fever - Temperature of 100.6F; Vomiting; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever - Temperature of 100.6F) and VOMITING (Vomiting) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Mar-2021, the patient experienced PYREXIA (Fever - Temperature of 100.6F) and VOMITING (Vomiting). The patient was treated with IBUPROFEN for Fever and Vomiting, at a dose of 1 dosage form. At the time of the report, PYREXIA (Fever - Temperature of 100.6F) and VOMITING (Vomiting) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-Mar-2021, Pyrexia: 100.6 (High) high.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication provided. Treatment information included Ibuprofen.
Patients shot record had stated she need a second dose of her Influenza as of 10/25/22. Therefore we gave her a dose of Influenza on 12/02/2022. When entering the vaccine it was charted that she received a dose of Influenza on 11/29/2022, but it was not reflected on her record. This meaning the patient had received a third dose of Influenza.  Doctor was notified and ensured that the extra dose would not harm her. As of the patient leaving our office she had no medically adverse reactions, she had just received an extra dose.
Had a Headache - missed a day of work    Took Tylenol all Day.
Within an hour and a half I became dizzy and had pain in the back of my head near neck.  My tongue felt swollen. I had body aches over night. With second dose within 4 hours my legs and arms were sore and I was dizzy(vertigo) it?s been 3 months and I still have sore muscles and vertigo.
generally was tired; Minor stomach upset on night of 26Nov-27Nov due to believed diet; Feeling nauseous/they believe nausea is a flare up of this; Vomiting; anxiety/chronic anxiety; runny nose; coughing a little; chronic sinus issues; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A 27 year-old female patient received COVID-19 Vaccine - Manufacturer Unknown, (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. Relevant medical history included: "COVID-19" (unspecified if ongoing), notes: Has gotten covid in the past., if covid prior vaccination: Yes; "Alcohol" (unspecified if ongoing), notes: Alcohol and cannabis-related use throughout past couple days.; "Nausea" (unspecified if ongoing), notes: History of nausea in the morning due to anxiety; "anxiety" (unspecified if ongoing), notes: History of nausea in the morning due to anxiety; "cannibis use" (unspecified if ongoing), notes: Some recreational CBD or cannibis use. The patient's concomitant medications were not reported. The following information was reported: NAUSEA (non-serious) with onset 25Nov2021 10:00, outcome "recovering", described as "Feeling nauseous/they believe nausea is a flare up of this"; VOMITING (non-serious) with onset 25Nov2021 10:00, outcome "recovering", described as "Vomiting"; ANXIETY (non-serious) with onset 25Nov2021 10:00, outcome "unknown", described as "anxiety/chronic anxiety"; RHINORRHOEA (non-serious) with onset 25Nov2021 10:00, outcome "unknown", described as "runny nose"; COUGH (non-serious) with onset 25Nov2021 10:00, outcome "unknown", described as "coughing a little"; SINUS DISORDER (non-serious) with onset 25Nov2021 10:00, outcome "unknown", described as "chronic sinus issues"; FATIGUE (non-serious) with onset 26Nov2021, outcome "unknown", described as "generally was tired"; ABDOMINAL DISCOMFORT (non-serious) with onset 26Nov2021, outcome "recovered" (27Nov2021), described as "Minor stomach upset on night of 26Nov-27Nov due to believed diet". Therapeutic measures were taken as a result of nausea, vomiting.  Additional information : It was reported that reporter believed unrelated to vaccine but woke up with runny nose, coughing a little, and feeling nauseous and vomiting. Unsure what brand of vaccine and number of doses. It was believed that, been vaccinated for a while now (not recent), but unsure when initially vaccinated. Patient has chronic sinus issues due to tongue size in proportion to mouth. Patient felt nauseous again and believed still due to chronic anxiety. On 27Nov2021 experienced nausea, vomiting still continued and still believed to be due to chronic anxiety. Cannabis related substances (not CBD). It was reported that nausea issue could be exasperated by drinking alcohol the night before and chugged water which may have caused vomiting. Took Dramamine and seemed to improve slightly during the day (based on observation)  The lot number for COVID-19 Vaccine - Manufacturer Unknown was not provided and will be requested during follow up.
12 year old patient received a 1st dose; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (12 year old patient received a 1st dose) in a 12-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jul-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (12 year old patient received a 1st dose). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (12 year old patient received a 1st dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.  No treatment information was provided.
Left forearm rash. Using Tylenol, topical numbing cream. See previous vaccine adverse event recorded this AM. No changes. Advised to contact PCP if rash is getting worse.
Chills/shakes   extremely cold  aches from head to feet . Head ache.
The patient came into the pharmacy on 7/12/2017 after receiving PNEUMOVAX on 7/11/2017 with an adverse reaction. The arm where the vaccine was administered was very red, warm, and edematous. The patient also reported that the area that was red was also very itchy. It looked like a delayed allergic reaction or some kind of cellulitis. The patient was told to take BENADRYL for the local reaction and follow-up with her provider. The patient did not report any known allergies or signs of anaphylaxis. Then the patient went to the doctor's office, where she was prescribed prednisone and cephalexin.
Relapse of gastroparesis. My gastroparesis had been much better. As expected, I got sick after the vaccine. After this, my gastroparesis symptoms got worse and have stayed that way since.
Pt developed extreme fatigue, lower back pain, and abdominal area swelled. Pt complained of severe pain, nausea, chills, and inability to move. Pt went to ER on 9/28/01 at 5 AM and was given pain pills. She was told to go to ER if not better in 2 days. She was given a referral to a specialist.
Vaccine Administered at Inappropriate Site; pain at injection site; redness at injection site; swelling at injection site; hot to touch at injection site; This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 58-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 25th March 2019, the patient received Shingrix (subcutaneous). On 25th March 2019, less than a day after receiving Shingrix, the patient experienced injection site pain, injection site erythema, injection site swelling, injection site warmth and intramuscular formulation administered by other route. On an unknown date, the outcome of the injection site pain, injection site erythema, injection site swelling and injection site warmth were recovered/resolved and the outcome of the intramuscular formulation administered by other route was unknown.   It was unknown if the reporter considered the injection site pain, injection site erythema, injection site swelling and injection site warmth to be related to Shingrix.  Additional case details were reported as follows: The injection was given behind the left arm and was given subcutaneously, which led to intramuscular formulation administered by other route. The injection site was painful, red, hot to the touch, and swollen.  The symptoms were lasted for about 5 weeks and then resolved. The reporter gave permission to follow up.
Chills; feeling very hot; arm also swelled, about 3 inches around the site; arm also swelled, about 3 inches around the site/ it was red and itchy; arm also swelled, about 3 inches around the site/ it was red and itchy; she woke up in a horrible sweat; This is a spontaneous report from a contactable consumer (patient). A 78-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EJ1284, expiry date: 30Apr2021), via an unspecified route of administration upper arm probably only about 4inches down from shoulder blade on the left on 12Jan2021 18:00 at a single dose for COVID-19 immunization. Medical history included COVID on 01Oct2020. Concomitant medication included rivaroxaban (XARELTO) as blood thinner. The patient previously took a flu and shingles shot and experienced her redness and swelling on her arm. The patient did not have vaccinations four weeks prior, and no additional vaccines were administered on the same date. She got it because she was told by her doctor that her antibodies will not last forever and it was still necessary to get it even though she already had COVID antibodies. She contracted COVID on 01Oct2020, that was the date when she had a positive test then she was last tested in December and she still had the antibodies then. She received her first dose of the vaccine on Tuesday 12Jan2021 and 24 hours later on 13Jan2021, she experienced chills and feeling very hot, which she took Tylenol extra strength for and it disappeared the next day. Her arm also swelled, not the whole arm, she would say about 3 inches around the site, 4 inches at the most and it was still swollen, it was red and itchy. Then she woke up in a horrible sweat but by the following morning it was gone. She wouldn't say it was a horrible reaction but she wanted to be certain she can go ahead and get the second shot which she had an appointment for. She said everything has resolved completely except for the swelling, her arm was still swollen, itchy, and red. Since the swelling, redness and itchiness began she would say it was slightly better than it was. The patient received the vaccine at an independent assisted living facility, not a military facility. The adverse events did not require a visit to the emergency room or physician's office. Outcome of the events chills, feeling very hot and woke up in a horrible sweat was recovered on 14Jan2021, while the remaining events was recovering.
Patient missed her menstrual period; Bones hurt so bad; Patient felt very lethargic; bodyaches for 2 weeks, from shoulders to fingers,knees to toes; This spontaneous case was reported by a consumer and describes the occurrence of AMENORRHOEA (Patient missed her menstrual period), BONE PAIN (Bones hurt so bad), LETHARGY (Patient felt very lethargic) and MYALGIA (bodyaches for 2 weeks, from shoulders to fingers,knees to toes) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Penicillin allergy, Latex allergy and Multiple sclerosis (since she was 14 years old). Concomitant products included ARIPIPRAZOLE (ABILIFY), BUSPIRONE and MULTIVITAMINS [VITAMINS NOS] for an unknown indication.   On 27-Nov-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Dec-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-Dec-2021, the patient experienced AMENORRHOEA (Patient missed her menstrual period), BONE PAIN (Bones hurt so bad), LETHARGY (Patient felt very lethargic) and MYALGIA (bodyaches for 2 weeks, from shoulders to fingers,knees to toes). On 10-Jan-2022, BONE PAIN (Bones hurt so bad) and MYALGIA (bodyaches for 2 weeks, from shoulders to fingers,knees to toes) had resolved with sequelae, LETHARGY (Patient felt very lethargic) had resolved. At the time of the report, AMENORRHOEA (Patient missed her menstrual period) had not resolved.            Symptoms like body aches for 2 weeks, from shoulders to fingers and from knees to toes, her bones hurt so bad have improved but there were residual effects.  On 27Dec2021, patient was in her menstrual period, but after getting the vaccine, it stopped completely, and not returned yet. She had no changes in blood levels, and she never missed her period before.  No treatment was given for her symptoms.  Patient would be visiting a gynecologist next week.   This case was linked to MOD-2022-502634.
This spontaneous report as received from a nurse refers to an unspecified number of patients of unknown age and gender. There was no information about the patients' concurrent conditions, concomitant therapies or medical histories provided. On unknown dates, the patients were vaccinated with improperly stored doses of GARDASIL 9 injection (dose, lot #, expiry date, anatomical location and route of administration were not reported). No adverse reactions were reported. Product quality complaint (PQC) was not involved. This is one of several reports received from the same reporter. Additional information has been requested.
I started having nausea, headache and nasal congestion at 2:54 pm on 12/19/2020.  This lasted until 12/21/2020 at 9:23 pm.  I had tried Sprix, Zomig 5mg and Promethazine 12.5mg.  The nausea went away, but the headache persisted.  I had originally thought it was a migraine and treated it as such, but my rescue medications did not work, so I thought it could be a side effect of the vaccination.
Immediately after I got the vaccine,  I tested sugar, in the back of my throat, like fake sugar. After 12 hrs. I got headache and fever (104.6) ( could have  be higher) I took a cold shower, to get temperature down. I cracked my teeth guard from my jaw, and I have brain fogs and hard time finding words. I have a PHD and now I can?t think. Affected my memory and speech, I have joint pain. I called and they told me to go to ER if fever reaches 105 but I managed to have the temperature down, so I did not have to go back.
Narrative: Patient reported injection site pain and numbness following administration of pfizer covid vaccine. The patient additionally reported anxiety, lightheadedness, dizziness, and weakness. The patient was observed for additional period with improvement. No intervention was needed and patient was able to released without issue.